NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.25% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.18% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.05% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.03% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.95% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.79% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.77% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.64% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.25% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.53% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.36% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.11% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.90% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.89% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 2.82% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.78% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 2.74% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.74% |